ClinicalTrials.gov
public full text
Public Domain
MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies
This research study is evaluating the feasibility of conducting cancer genetic testing using healthy skin cells among participants with a diagnosis of a blood cancer. Additionally, investigators will evaluate how often participants with blood cancers are found to have risk for cancer based on family genes.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD#1089126
- Germline genomic testing to assess the suitability of stem cell donors in the treatment of haematological malignancy: clinical ethics commentary#276061
- Key Longitudinal Associations With Risk and Glioblastoma Outcomes#804518
- Integrative Mutation-Centered Transcriptomic Analysis of Driver-Specific Programs and Biomarker Candidates in Acute Myeloid Leukemia#403991
- Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia#825840
Record · ID 1058099
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive